Insider Sale: Director at $NTRA (NTRA) Sells 2,100 Shares
Insider Sale: Director at $NTRA (NTRA) Sells 2,100 Shares
Gail Boxer Marcus, a director at $NTRA ($NTRA), sold 2,100 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 17.8% of their shares. Following this trade, they now own 9,704 shares of $NTRA stock.
$NTRA($NTRA)的董事蓋爾·博克瑟·馬庫斯於2024年11月19日出售了該公司的2,100股股票。我們從美國證券交易委員會最近的一份文件中收到了交易數據。這是他們約17.8%的股份的出售。在這筆交易之後,他們現在擁有9,704股NTRA股票。
$NTRA Insider Trading Activity
$NTRA 內幕交易活動
$NTRA insiders have traded $NTRA stock on the open market 115 times in the past 6 months. Of those trades, 0 have been purchases and 115 have been sales.
在過去的6個月中,NTRA內部人士在公開市場上交易了115次NTRA股票。在這些交易中,0筆是購買,115筆是銷售。
Here's a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
以下是內部人士在過去6個月中最近對$NTRA股票的交易明細:
- GAIL BOXER MARCUS has traded it 8 times. They made 0 purchases and 8 sales, selling 13,894 shares.
- ROY D. BAYNES has traded it 6 times. They made 0 purchases and 6 sales, selling 37,230 shares.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has traded it 27 times. They made 0 purchases and 27 sales, selling 82,243 shares.
- JONATHAN SHEENA has traded it 37 times. They made 0 purchases and 37 sales, selling 89,800 shares.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has traded it 16 times. They made 0 purchases and 16 sales, selling 19,025 shares.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has traded it 7 times. They made 0 purchases and 7 sales, selling 8,342 shares.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has traded it 6 times. They made 0 purchases and 6 sales, selling 5,138 shares.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has traded it 6 times. They made 0 purchases and 6 sales, selling 6,468 shares.
- ROWAN E CHAPMAN has traded it 2 times. They made 0 purchases and 2 sales, selling 7,470 shares.
- 蓋爾拳擊手馬庫斯已經交易了8次。他們進行了0次買入和8次銷售,賣出了13,894股股票。
- 羅伊·貝恩斯已經交易了6次。他們進行了0次購買和6次銷售,出售了37,230股股票。
- 史蒂芬·倫納德·查普曼(首席執行官兼總裁)已經進行了27次交易。他們進行了0次買入和27次銷售,賣出了82,243股股票。
- 喬納森·希納已經交易了37次。他們進行了0次購買和37次銷售,出售了89,800股股票。
- 邁克爾·伯克斯·布羅菲(首席財務官)已經進行了16次交易。他們進行了0次購買和16次銷售,出售了19,025股股票。
- 約翰·費斯科(總裁,首席巴士。OFFICER) 已經交易了 7 次。他們進行了0次購買和7次銷售,出售了8,342股股票。
- 所羅門·莫什克維奇(臨床診斷總裁)已經進行了6次交易。他們進行了0次購買和6次銷售,出售了5,138股股票。
- 丹尼爾·拉比諾維茨(秒而且(首席法務官)已經進行了6次交易。他們進行了0次購買和6次銷售,賣出了6,468股股票。
- ROWAN E CHAPMAN 已經交易了 2 次。他們進行了0次購買和2次銷售,出售了7,470股股票。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要追蹤內幕交易,請查看Quiver Quantization的內幕交易儀表板。
$NTRA Hedge Fund Activity
$NTRA 對沖基金活動
We have seen 242 institutional investors add shares of $NTRA stock to their portfolio, and 259 decrease their positions in their most recent quarter.
我們已經看到242名機構投資者在其投資組合中增加了NTRA股票的股票,259名機構投資者在最近一個季度減少了頭寸。
Here are some of the largest recent moves:
以下是近期一些最大的走勢:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,341,756 shares (+442.8%) to their portfolio in Q3 2024
- WELLINGTON MANAGEMENT GROUP LLP added 1,883,481 shares (+205.4%) to their portfolio in Q3 2024
- DUQUESNE FAMILY OFFICE LLC added 1,591,970 shares (+80.6%) to their portfolio in Q3 2024
- BLACKROCK, INC. added 1,461,550 shares (+21.6%) to their portfolio in Q3 2024
- JPMORGAN CHASE & CO removed 1,433,790 shares (-23.6%) from their portfolio in Q3 2024
- FRED ALGER MANAGEMENT, LLC removed 1,250,664 shares (-23.8%) from their portfolio in Q3 2024
- AMERIPRISE FINANCIAL INC removed 861,463 shares (-26.0%) from their portfolio in Q3 2024
- PRICE t ROWE ASSOCIATES INC /MD/ 在 2024 年第三季度在其投資組合中增加了 2,341,756 股(+442.8%)
- 惠靈頓管理集團有限責任公司在2024年第三季度在其投資組合中增加了1,883,481股股票(+205.4%)
- 杜肯家族辦公室有限責任公司在2024年第三季度在其投資組合中增加了1,591,970股股票(+80.6%)
- 貝萊德公司在2024年第三季度在其投資組合中增加了1,461,550股股票(+21.6%)
- 摩根大通在2024年第三季度從其投資組合中刪除了1,433,790股股票(-23.6%)
- 弗雷德·阿爾傑管理有限責任公司在2024年第三季度從其投資組合中刪除了1,250,664股股票(-23.8%)
- AMERIPRISE FINANCIAL INC在2024年第三季度從其投資組合中刪除了861,463股股票(-26.0%)
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要追蹤對沖基金的股票投資組合,請查看Quiver Quantization的機構持股儀表板。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不是財務建議。有關更多信息,請參閱 Quiver Quitizative 的免責聲明。